Since the NF-κB pathway has an essential role in adaptive response and cell survival [39], increasing evidence suggests that deregulation of NF-κB and its regulatory kinases play a contributing role to cancer development, progression, and resistance to chemotherapy [40]–[41]. The gene discussed is NFKB1; the disease is cancer.